CorneaCare, Inc.

D2C dry eye solution steamlining diagnosis, treatment, compliance and education

Last Funded October 2021

$65,000

raised from 7 investors

Highlights

1
Dry eye disease afflicts 30m+ US adults; aging population, increased screen time, contact lens use
2
With 1.0% market capture (300,000 patients), CorneaCare could generate $126M of revenue per annum (not guaranteed)
3
Our eCommerce portal provides convenient and effective treatment packages delivered monthly.
4
Our digital therapeutic app promotes treatment compliance, monitoring, and collaborative care.

Featured Investor

Our Team

Large total addressable market; current treatment options are not effective

Pitch

We hope to generate revenue from a monthly subscription plan.

Overview